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PREFACE 
The mechanism of action of antibiotic resistance 
inherent in the readily extractable lipids (REL) and 
lipopolysaccharides (LPS) in Pseudomonas aeruginosa was 
studied. The REL of rifamycin resistant strains was 
compared to the REL of polymyxin resistant strains. Selected 
components of LPS of polymyxin-resistant and susceptible 
strains were analyzed to determine which component 
contributes the most in the exclusion mechanism of the outer 
membrane. 
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Pseudomonas aeruginosa is of great concern to the medical 
community because it is the primary opportunistic pathogen 
in severely compromised hosts such as burn patients and 
cystic fibrotic children. Pseudomonas species are the 
primary pathogens associated with chronic progressive 
pulmonary disease in the victim of cystic fibrosis . Cystic 
fibrosis is the number one cause of lethal genetic disease 
in the United States among white children. Between 40-90% of 
cystic fibrosis patients have chronic respiratory tract coloni-
zation with ~ aeruginosa. Cystic fibrosis is a hereditary 
disease of the epithelial tissue affecting primarily the 
secretion of the various exocrine glands, resulting in a 
generalized dysfunction of the glands. The heterozygous 
parents of a child with cystic fibrosis are asymptomatic. 
Genetic studies cannot distinguish between homozygotes, 
heterozygotes and normals because no single molecular 
abnormality has yet been identified as being altered by the 
genetic defect (10,34). 
Most cystic fibrosis patients develop varying degrees 
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of recurrent pulmonary deficiency, digestive and nutritional 
problems secondary to pancreatic deficiency, and highly 
elevated sweat electrolytes (18). Much of the pathology of 
the disease is caused by over-secretion of viscous mucus 
resulting in obstruction and subsequent fibrosis of the 
pancreatic ducts, hepatic ducts and bronchioles. The 
copious mucus secretions interfere with pulmonary clearance 
of microorganisms (48). Most infants can with proper care 
now survive these complications and live w~ll into their 
third decade of life but all eventually succumb to chronic 
bronchitis and recurrent infection of Pseudomonas in 
the respiratory tract (36). 
Infection in cystic fibrosis patients normally begin 
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with pathogenic strains of Hemophilis or pneumococcus, then 
switch to Staphylococcus and then invariably to Pseudomonas 
(33,35). Apparently Pseudomonas finds a favorable environment 
for colonialization in the abundant static bronchial 
secretions of the lungs. Pseudomonas infection in the 
lungs of cystic fibrosis patients cause fibrosis and 
calcification presenting similar radiographs found in 
Mycobacterium infections and as a result cystic 
fibrosis and tuberculosis are often confused (35). ~ 
aeruginosa can injure pulmonary tissue directly with 
local nonspecific or specific host immune response 
(10,33,48). ~ cepacia infections in cystic 
fibrosis patients are rare but when they occur they have 
been associated with septicemia leading to rapid progression 
toward respiratory failure and death (34). 
Atypical smooth mucoid strains of Pseudomonas 
aeruginosa are common in cystic fibrosis patients. 
These patients normally have high antibody titers to the 
bacteria's mucoid layer (10). Approximately 80% of 
Pseudomonas from cystic fibrosis patients are mucoid 
strains compared to the 0.8-1.2% found in the general 
population (41). Evidence is clear that specific immune 
systems, including the humoral immunity and cell immunity, 
in cystic fibrosis patients appears normal (26,27). This 
suggests that some deficiency exists in the host mechanisms 
in the respiratory tract, such as the alveolar macrophages. 
Prophylactic immunization is effective in preventing upper 
respiratory tract colonization but is of little benefit once 
the mucoid strain colonize in the tissue because the 
antigenic-determinants for opsonic antibody are blocked by 
the mucoid layer (10,41). 
~ aeruinosa, ~ cepacia and Staphylococcus aureus 
infections of cystic fibrosis patients are located almost 
exclusively in pulmonary tissue (10). Cystic fibrotic 
patients usually deteriorate and succumb to the combined 
effects of the metabolic defects and the presence of the 
antibiotic-resistant bacterial strains. The choice of 
antimicrobials in the treatment is difficult and often 
arbitrary. The concentration of the antibiotic should be 
two to four times the minimum inhibitory concentration (MIC) 
of the infecting bacteria at the site of infection (33). 
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McLaughlin performed pulmonary function tests of cystic 
fibrosis patients who had been treated with antibiotics over 
a period of ten days. Improvement in pulmonary function did 
not correlate with a change in the sputum bacterial 
concentration, antibiotic susceptibility of bacteria present 
in sputum, or antibiotic administered. At the end of one 
month after treatment, the concentration of bacteria 
measured in the sputum returned to pretreatment levels. 
Neither antibiotics or antipseudomonal antibody protect the 
pulmonary system against Pseudomonas infection 
(10,36). Pseudomonas is rarely eradicated from the 
sputum (3). Several aminoglycosides, such as tobramycin and 
gentamicin have demonstrated efficiency against 
Pseudomonas. They have the disadvantage of 
vestibuloauditory and renal toxicities at high 
concentratons. Poor clinical results may reflect lack of 
compliance, incorrect recogniton of the infecting bacteria 
or failure to achieve adequate concentration of active drug 
in sputum or bronchial tissue (33). 
Polymyxin 
In this study I examined a wild type Pseudomonas 
strain which was stepwise adapted to polymyxin, giving us 
the strain IA, and a deadapted strain IA-Reverted (IAR). 
The polymyxins are one of the few groups of antibiotics that 
can be used successfully against pseudomonal infections (6). 
Polymyxin is a basic peptide antibiotic with a molecular 
~eight of approximately 1200, having amphiphilic properties 
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with a charged hydrophilic headgroup and a hydrophobic side 
chain (Figure 1) (24). 
It is usually used in atopic ointments, being administered 
to cystic fibrosis patients only as a last resort. 
Polymyxin is a broad spectrum antibiotic effective against 
gram-negative bacteria, yeast and protozoa (45). It can be 
useful clinically as it has lower toxicity for eucaryotic 
cells. It is active against most ~ aeruginosa 
isolates with an MIC of <2~/ml. Polymyxins have been 
compared to a cationic detergent. However, polymyxins 
exhibit bactericidal activities at lower concentration and 
slight modifications in the antibiotic results in 
significant changes in biological activities (45). 
This study also examined several Pseudomonas 
strains and their stepwise adaptation to rifamycin. 
Rifamycin is an amphiphilic antibiotic having an aromatic 
chromophore spanned by a long aliphatic bridge and as a 
result is more nonpolar than polymyxin (Figure 2) (8). It 
is bactericidal and functions by blocking transcription at 
the initiaton step, specifically, RNA polymerase. Rifampin 
is a semi-synthetic derivative of the naturally occurring 
rifamycins and is widely used clinically. It is selective 
for acid-fast and gram-negative procaryotes and therefore 
useful in selective antibacterial chemotherapy. 
The permeability charateristics of the outer membrane (OM) 
of the polymyxin-resistant cells used in this study appear 
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Gilleland and Farley, the MIC changes for polymyxin coincide 
with MIC changes in rifamycin (17). As the wild type 
strain, PAOl, was adapted to polymyxin B it become more 
sensitive to rifamycin which is more nonpolar than polymyxin 
B (19). In this same study, the MIC changes for polar 
antibiotics were unaffected thereby giving credence to the 
hypothesis that hydrophilic antibiotics diffuse through 
acqueous porins, whereas hydrophobic antibiotics utilize the 
hydrophobic hydrocarbon inner leaf of the OM. 
Exclusion Mechanism 
The OM of gram-negative bacteria plays an important 
role as an ionophore size-dependent permeability barrier and 
in resistant cells fuction to exclude antibiotics, such as 
polymyxin Band rifamycin (Figure 3) (33,44,50). It is 
permeable to saccharides of molecular weight between 
3000-9000 Daltons (22). Outer membrane permeability 
decreases as antibiotic resistance increaseg (1). The 
primary sites of interaction on the OM surfuce are the 
phospholipids and the lipopolysaccharides (LPS) (38). Storm 
and Rosenthal hypothesized polymyxin B disrupts the membrane 
structure by electrostatic interactions with phospholipids 
(45). This change is sufficient to increase permeability of 
the lipid barrier with respect to charged or polar 
molecules. The fatty acid chain on the polymyxin 
B molecule is shorter (Ca - C11) than the fatty acid chains 
of the phospholipids (Cl4 - C1a) (21). The insertion of the 
var~~:i:.l~~~ I I I . I L Ill ) Ir j . OM porin If 1!1 I 
() \) \) \) \) \) () \) () \) \) \) ;i; \) \) \) 8~ 
core & lipid A~IJJIJ(Q)JJJ ~ JJI ~~:~ JIJe 
phospholipid~..... • •••••• ~~~ •••• 
[I) I I Ill • I LPS \) \) \) \) \) ~f \\ • •••••• 
peptidogycan~:::::::::::::-----------------------------------Jl----~--~~~~::::~~ 
membrane / •••••• ~.~.::.:. ••••••••• ~·%: • • )'". ••••• ~ ••• proteins C) \) \) \) \) \) ~;..€1 () \) () () \) \) \) \) () ··~·' \) \\ ]:" () (\ \) (\ (\ .f~ (\ (\ (\ 
\) \) \) ~) () \) ~-~ ~) \) (\ \) ~ \) \) \) \) \) \) \) 61 \) \) \) \) \) ~·~ \) \) \) 
•••••• ;:~ •••• ~······· -~· ••••• ·~r. ••• 
Figure 3. Outer Membrane of Gram-Negative Bacteria 
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shorter chains into the hydrophobic interior causes a 
disruption of the lattice structure. The interaction of the 
positively charged peptide head with the negatively charged 
phosphates causes a widening of the structure and 
consequently an 11% increase in the area. Few demonstrated 
increased surface pressure on phospholipid monolayers by 
external polymyxin B. The pressure could be caused by the 
insertion of the fatty acid tails into the hydrophobic core 
of the OM or by electrostatic force due to interactions 
between peptide amino groups and phospholipid phosphate 
groups (45). 
Binding of polymyxin to the OM can be inhibited by 
divalent cations. Magnesium and calcium ions act as 
metal-ion bridges between the phosphate groups of the 
phospholipids and the LPS to preserve the OM structural 
integrity (45). 
Gilleland and Murray suggested that exclusion of 
nonpolar antibiotics by the OM might be the mechanism of 
resistance. They subjected cells to cold shock and osmotic 
cold shock and found no evidence for a polymyxin-
inactivating enzyme in osmotic shock fluid from the 
polymyxin~resistant strains (19). This is further supported 
by electron microscopy studies of isolated cytoplasmic 
membrane (CM) and OM from resistant and susceptible strains 
(17). Polymyxin disrupted the OM and CM of susceptible 
cells and the CM of resistant cells, leaving the OM of the 
resistant cells unaffected. 
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The exclusion mechanism for the resistance of polymyxin 
on the OM of ~ aeruginosa may be explained by 
way of at least two possible hypotheses, or some combination 
thereof. The first hypotheses encompasses two model 
systems. In the first model it is assumed that the 
hydrophobic paraffin tail of the polymyxin molecule slides 
in-between the lipid bilayer of the OM, leaving the 
hydrophilic, charged headgroup lying flat against the outer 
surface. The result would be an expansion of the lipid 
lattice and a tilting of the lipid chains which would lead 
to a disruption in the fluidity and permeability of the OM 
thereby allowing the antibiotic to enter. The second model 
requires the entire polymyxin molecule to enter the lipid 
bilayer causing a disruption of the lipid lattice and 
resulting in a complete disorganization of the membrane 
structure. In both models it should be clear that if the 
lipid content and composition were to be altered, through a 
loss of receptor phospholipid, antibiotic resistance might 
result since polymyxin could no longer bind and interact 
with the OM layer. 
The second theory for polymyxin resistance suggests 
that the antibiotic penetrated the OM via an OM porin after 
first being bound to LPS or OM phospholipid (12). Here, the 
exclusion mechanism works through a loss of porin protein 
which can no longer facilitate passage of the antibiotic. 
Once through the OM, polymyxin is free to reach its 
target sites on the cytoplasmic membrane (CM). The 
bactericidal action of polymyxin on gram-negative bacteria 
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results from the interaction of the antibiotic with the 
phospholipids in the CM causing leakage of the cell contents 
(2). The CM and OM of sensitive cells both bind polymyxin B 
in equivalent amounts per mole of lipid phosphate (45). A 
specific protein receptor seems unlikely in view of the fact 
that binding of polymyxin B to the membrane shows saturation 
at concentrations of one to two orders of magnitude higher 
than MIC or minimum inhibitory bacteriocidal (MIB) 
concentrations. Based on an experiment with agarose beads, 
Teuber hypothesized that polymyxin B did not have to enter 
the cell to inhibit growth, only surface contact was 
necessary (45). Biosynthesis, for instance, depends on the 
energy charge of the cell. Polymyxin B binding to the OM 
surface disrupts the energy charge thus causing general 
inhibition by inhibiting electron transport and oxidative 
phosphorylation. As polymyxin concentration increases, the 
efflux of cytoplamic components into the media occurs and 
permeability for small molecular weight compounds increases. 
Divalent cations inhibit this effect (45). 
The initial interaction of the polymyxin molecules with 
the gram-negative bacterial OM involves binding to LPS and 
phospholipids (2,25,38,39). It has been reported by a 
number of workers that polymyxin-resistant strains of 
~ aeruginosa have alterations in their lipid 
content and composition in the OM (2,3,5,12,18). Dorrer and 
Teuber reported that lipids on the polymyxin-resistant 
strains are altered when grpwn on various carbon sources 
(24). Conrad reported polymyxin resistant strains had a 
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significant increase in the readily extractable lipid (REL) 
content and a significant decrease in selected phospholipids 
(4). ·-·The reduction of overall phospholipid content, 
specifically phosphatidylglycerol (PG), and 
phosphatidylethanolamine (PE), could reduce the ability of 
the OM to bind to polymyxin B. There was a significant 
increase observed also in the unsaturated straight chain 
fatty acids accompanied by a significant decrease in the 
cyclopropyl fatty acids in polymyxin-resistant strains as 
compared with PAO and the deadapted strain, IAR (4). 
The polymyxin B adapted Pseudomonas strain used 
in our study has been previously shown to have reduced 
amounts of three major OM porin proteins (19), having 
approximate molecular weights of 24,000, 36,500 and 47,000 
(2). The loss of major porin proteins of polymyxin-
resistant strains was found to be dependent on the carbon 
sources (6,16). It should be noted that in Conrad and 
Gilleland's polymyxin-resistant strain, the loss of OM porin 
protein was accompanied by lipid alterations (4). 
Polymyxin resistance could be explained by a combined 
effect of the exclusion mechanism by the OM with an 
antibiotic deactivating enzyme in the periplasmic space, 
loss of sensitivity of the active site in the CM, and a 
repair mechanism that repairs damage to the CM (1,17). 
There is, however, no evidence to support these mechanisms. 
13 
Lipopolysaccharide 
The lipopolysaccharide (LPS) component of the OM of 
gram-negative bacteria consists of three regions, Lipid A, 
core oligosaccharides and 0-antigenic side chains (31). The 
three regions are covalently attached to one another. Lipid 
A, the hydrophobic component, consists of a diglucosamine 
pho~phate with five or six attached fatty acid chains and is 
inserted into the outer leaflet of the OM (32). A 
significant portion of the fatty acid chains are 2- or 
3-hydroxyl fatty acids, which are unique to LPS in 
gram-negative bacteria (28,42). The core consists of about 
ten to twelve sugars and contains most of the cellular 
octose and heptose present as 3-keto-D-mannooctulosonic acid 
(KDO) and 1-glycero-D-mannoheptose or 
D-glycero-L-mannoheptose respectively, as well as a number 
of hexoses. The side chain consists of a variable number of 
repeating saccharide units and is the portion of the LPS 
which usually determines antigenic specificity (8,36) and 
heterogeniety (20,25). 
The LPS is a permeability barrier to antibiotics, an 
obstacle to the functioning of phagocytes and antibodies, 
and functions as a receptor site for the adsorption of some 
bacteriophage (36). It is important to note that the cell 
controls the LPS to maintain a fixed surface charge (9). 
Polymyxin B disrupts this surface charge by crossing the OM 
of Pseudomonas via a pathway in which the cationic 
antibiotic interacts with a magnesium ion binding site on 
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the OM LPS. The phospholipids and LPS are forced further 
apart altering the surface charge consequently making the OM 
more permeable to other antibiotics (40). 
Polymyxin B has been hypothesized to bind primarily 
with the KDO portion of the LPS molecule according to a 
study in which the peptide-lipid portion contained 
approximately three moles of antibiotic per one mole of LPS 
(45). In another study, it was reported that the level of 
LPS was decreased in the polymyxin-resistant strains as 
compared to the wild type PAOl strain (18). 
Since cystic fibrosis patients are susceptible to ~ 
aeruginosa and Pseudomonas quickly acquires resistance to 
most antibiotics, antimicrobial agents and physio-therapy, 
it would be of value to determine the mechanism of action of 
antibiotic resistance inherent in the OM of 
Pseudomonas. Results from our rifamycin experiments 
will allow us to determine whether the conclusions derived 
from the polymyxin studies which analyzed REL were unique to 
polymyxin or can be applied to nonpolar antibiotics in 
general. This will give a clue to the mechanism of action 
of resistance to rifamycin-resistant cells. Both mechanisms 
of polymyxin penetration through the OM and consequent 
interaction on the CM are hypothesized to function together. 
The question remains as to whether lipids or proteins or 
both play a crucial role in bringing about polymyxin 
resistance. Our working hypothesis in this study was that 
acquisition of polymyxin resistance results from alterations 
in the LPS component, the component most likely to have the 
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greatest effect on the OM permeability. Here we are 
concerned with the qualitation and quantitation of LPS in 
resistant and susceptible cells to determine which component 
was responsible for the exclusion of polymyxin B in the OM 
of resistant cells. 
CHAPTER II 
METHODS AND MATERIALS 
Bacterial Strains 
The polymyxin-resistant strains of ~ aeruginosa 
used in this study have been previously described by Conrad 
and Gilleland (4). The rifamycin-resistant strains (RIF G 
and RIF H) were derived during the present study and 
included RIF G and RIF H resistant strains. They were 
derived from the wild type PAOl strain. They are not 
stable mutants but represent an adaptive response to the 
presence of 6000 U of rifamycin per milliliter (ml) of 
growth medium. Adaptive cells grown in the absence of 
rifamycin reverted to rifamycin susceptibility. The 
polymyxin system included polymyxin-susceptible PAOl parent 
strain, polymyxin-resistant strain, isolate A (IA), which 
was adapted to 6000 U of polymyxin per ml of growth medium, 
and polymyxin-susceptible revertant, isolate A revertant 
(IAR). 
~ aeruginosa PAOl was grown at 30°C in a basal salts 
medium (BM) described below. Resistant strains to either 
polymyxin or rifamycin were obtained using the following 
method. All cultures were grown at 30°C in an 
Environ-shaker (LABLINE Instruments, Inc., type 3597-2), 
rotations at 180 rpm. PAOl was grown in BM and incubated 
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in 125 ml Erlenmyer screw-capped flasks containing twenty 
mls of BM or BM plus appropriate concentrations of either 
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polymyxin B or rifamycin SV. PAOl was adapted to resistance 
by repeated subcultures in the presence of increasingly 
greater antibiotic concentrations. The rifamycin-resistant 
strains were adapted by increasing the concentration from 
100 pg/ml after 42 hours to 250 pg/ml, then at 24 hour 
intervals increased to 500, 1000 then finally 2000 pg/ml. 
Using this method of transferring the cells from low 
concentrations to higher concentrations of antibiotics, 
cells were obtained which could grow in the presence of 6000 
U of polymyxin or 6000 U of rifamycin. Stock cultures of 
the isolates were maintained on BM or BM plus the 
appropriate antibiotic at 4°C and on agar plates at 
room temperature until needed. 
bimonthly. 
All strains were subcultured 
Media 
All cells were grown in a previously described basal 
medium of Gilleland and Murray (18). This medium contained 
the following ingrediants at a final pH of 7.0: 0.03 
M glucose, 0.04 M K2HP04, 0.022 M KH2P04, 0.007 M (NH4)2S04 
and 0.0005 M MgS04. All media minus glucose and 
antibiotics, which were added separately, were sterilized in 
an autoclave at 12l°C at 15 psi for 15 minutes. 
D-glucose was sterilized separately for twelve minutes and 
the antibiotics were filter sterilized by millipore filter 
(.45 pm) in a typeS Nalgene filtration unit. Rifamycin and 
polymyxin-containing media consisted of BM plus the 
appropriate concentration of antibiotic per ml. The 
polymyxin 8 sulfate was purchased from Sigma Chemical Co., 
and rifamycin SV was purchased from Applied Science Labs. 
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The cells were routinely grown in two- and four-liter 
Erlenmyer flasks containing one- and two-liters respectively 
of medium with either vigorous stirring using a magnetic 
stirring bar at 30°C or in a shaker at 180 rpm at 
30°C. A starter culture was used to innoculate the 
fresh flask of medium to give an initial absorbance of 0.05 
at 660 nm. The growing cells were monitored by measuring a 
20 ml aliquot in a Bausch & Lomb Spectronic 20. The cells 
were harvested at the mid- to late-logarithmic phase by 
centrifugation at 6500 rpm, or 8000 x g, at 0-4°C in a 
Sorvall RC-5 Superspeed Refrigerated Centrifuge (Du Pont 
Instruments), and washed twice with a 50 mM phosphate 
buffer at pH 7.0. The cells were stored frozen at 0°C 
and then freeze-dried in a LABCONCO Freeze-dryer-5 
lyophilizer. 
LPS Isolation 
Freeze-dried cells were used in the isolation of LPS in 
a method that extracted both smooth and rough LPS as 
described by Darveau and Hancock (7). Each extraction 
utilized either 0.5 to 2.5 g of cells. The freeze-dried 
cells were suspended in 10 mM Tris-hydrochloride 
(Tris-HC) buffer (pH 8.0), 2M MgCl2, 100 ~g of 
pancreatic DNase I (DNlOO; Sigma Chem. Co.) per ml, and 25 
pg of pancreatic RNase A (R-4875 Sigma) per ml. This 
suspension was passed twice through a French pressure cell 
(American Instrument Co.) at 15,000 lb/in2, The cell 
lysate was sonicated (Lab-Line Ultra-tip Labsonic System) 
for two 30 second bursts at a probe intensity of 75. DNase 
and RNase were added to final concentrations of 200 and 50 
pg/ml respectively, and the suspension was incubated at 
37°C for 2 hours. After the incubation period, 0.5 
M tetrasodium ethylenediaminetetra acetic acid (EDTA) 
(Sigma) dissolved in 10 mM Tris-HC (pH 8.0), 20% 
sodium dodecyl sulfate (SDS) dissolved in 10 mM 
Tris-HC (pH 8.0) and 10 mM Tris-HC (pH 8.0) were added 
to give a final concentration of 0.1 M EDTA, 2% SDS 
and 10 mM Tris-HC at a pH of ca. 9.5. The sample was 
vortexed and centrifuged in a Beckman Model 15-65 
Ultracentrifuge (Beckman Instrument Inc.), using a 
preparative TYPE 65 rotor) at 50,000 x g for 30 minutes at 
20°C. The supernatent was decanted, and pronase 
(Sigma) was added to give a final concentration of 200 
~g/ml, and the sample was incubated overnight in a shaker 
at 180 rpm at 30°C. Two volumes of 0.375 M MgCl2 in 95% 
ethanol were added and the mixture cooled to 0°C in a 
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preset refrigerator. After centrifugation at 12,000 x g for 
15 minutes at 0-4°C, the pellet obtained was suspended 
in 9% SDS-0.1 M EDTA, dissolved in 10 mM 
Tris-HCl (pH 8.0) and sonicated. The pH was lowered to 7.0 
by drop-wise additon of 6N HCl and incubated at 80°C 
for 20 minutes. The pH was then raised by drop-wise 
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addition of 4 N NaOH to 9.5, pronase added to 25 ~g/ml and 
the sample was then incubated overnight at 
37°C as before. Again, 0.375 ~ MgCl2 was added, 
the sample cooled to 0°C and centrifuged as before. 
The pellet obtained was suspended in 10 m~ Tris-HCl 
(pH 8.0), sonicated as before and centifuged at 1000 rpm for 
5 minutes. This step was repeated twice, decanting the 
supernatent each time, which was then centrifuged at 200,000 
x g for 2 hours at 15° in the presence of 25 m~ 
MgCl2. The pellet obtained was resuspended in 1 ml of 
distilled water and freeze-dried. 
LPS Analysis 
Total hexose and heptose were measured for by the 
sulfuric-acid method of Wright and Rebers (49). LPS was 
resuspended in 0.1 N H2S04 by sanification at a 
probe intensity of 75 for 30 seconds before starting the 
assays. D-glucose was used as the standard for the hexose 
assay. For the heptose assay, the sample was read at 505 
and 545 nm and the difference in these two ODs were taken. 
The proportionality was such that 1.0 change in the optical 
density was equal to 230 ~g of heptose. KDO was quantitated 
by the colorimetric assay described by Weissback and Hurwitz 
(47). Total carbohydrate was assayed by the phenol-sulfuric 
acid methods of Dubois and Gilles (11). Dextran was used as 
the standard. The phosphate content of LPS was measured by 
the Ames total phosphate method. For each assay, from 
10-100 ~g of lyophilized LPS was measured. The percent of 
LPS in the whole cells was determined gravimetrically after 
lyophilization. 
Lipid Analysis 
The REL fraction of the rifamycin strains was obtained 
by chloroform-methanol (2:1) extraction of 500 mg 
freeze-dried whole cells by a previously described 
modification ( 6) of the method of Folch et. al. (14). The 
percent of REL in whole cells were determined 
gravimetrically by evaporating 5 mls of extract to dryness 
at room temperature jor 48 hours in tared aluminum weigh 
pans. Qualitative resolution of major membrane 
phospholipids and separation from neutral lipids were 
performed on thin layer chromatography (TLC) plates. This 
was used for REL samples and as a check for LPS purity. A 
sample aliquot was dried under flowing N2 gas at 
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40°C and redissolved into a 0.1 volume of 
chloroform-methanol (2:1) or hexanes solvent. A 5 ~1 
deposition of concentrated sample was applied to the plate 
with a Pasteur pipet. The plates were first developed 10 em 
in chloroform:met~anol:water (65:25:4), dried at room 
temperature and then developed 14 em in 
n-hexane:diethylether (4:1). The TLC chamber (Analytical 
Technology) for both systems contained 125 ml of solvent. 
The glass plate was 20 x 20 em and had a silica gel G 
(Sigma) suspension spread to a 250~m thickness. Tentative 
identifications were made by comparision with reference 
standard lipids (Supelco and Applied Science Lab.). For 
quantitative analysis~ the plates were sprayed with 50% 
sulfuric acid in saturated KCr204 and charred 45 
minutes at 150°C in an oven. Relative densites were 
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read in a densitometer (E-C Apparatus Corp.). The phosphate 
content of the freeze-dried LPS was measured by the Ames 
total phosphate method (5). The Lowrey protein assay was 
used as a check for LPS purity with bovine serum albumin as 
a standard (7). 
Fatty acids from whole cells, REL and LPS were 
quantitated and qualitated by gas-liquid chromatography 
(GLC). Methyl esters were prepared by the boron 
trifluoride-methanol method of Metcalfe and Schmitz (37). 
Methyl esters were separated from non-esterfied fatty acids 
by using petroleum ether (30-60°):diethyl ether:glacial 
acetic acid (90:10:1). The characteristic yellow 
fluorescence of methyl esters was detected by ultraviolet 
light after the plate was sprayed with Rhodamine 6G (6 
mg/100 ml water). Methylated fatty acids were scraped into 
scintered glass filters and extracted by n-hexane. Whole 
cell and LPS fatty acids were saponified and methylated by 
the boron trichloride method as described in the Supelco 
bulletin #767A, used specifically for the identification of 
hydroxy-fatty acids. The methylated fatty acids were 
identified using a Hewlett-Packard 5840A GLC equipped with a 
flame ionization detector, glass column (6 ft. x 4 mm) 
packed with two support systems. The first column was 
packed with 3% SP-2100 DOH on 100/120 Supelcoport with an 
injection port temperature of 250°C and a detector 
temperature of 250°C. Column temperature was progammed 
to run for four minutes at 150°C then increased to 
225°C at a rate of 4°C per minute. The second 
support system used for REL methyl esters consisted of a 
glass column (6 ft x 4 mm) packed with 10% SP-2330 on 
100/120 Chromosorb, wih an injection port temperature of 
200°C and a detector temperature of 225°C. Column 
temperature was programmed to run four minutes at 100°C 
then increased to 200°C at a rate of l0°C per 
minute. The carrier gas flow for both systems was N2 
23 
at a rate of 40 ml per minute. Methyl esters were stored in 
hexane under N2 gas at -20°C. 
Statistics 
The statistical significance of the values obtained in 
the chemical analyses was determined by performing the 
Student t test on the mean, employing the two-tailed 




The percent readily extractable lipids (REL) in PAOl and 
the adapted rifamycin strains, RIF G and RIF H, were 
determined gravimetrically. Analysis of the percent REL 
demonstrated significant quantitative changes in RIF G, as 
compared to PAOl. The percent REL in RIF H remained 
unchanged. PAOl, RIF G, and RIF H percent REL was 12.43%, 
11.02% and 11.69% respectively (TABLE I). Percent phosphate 
was determined by the Ames total phosphate assay (14). RIF H 
REL was significantly changed in the phosphate content while 
the percent phosphate of RIF G remained unaltered. PAOl had 
a value of 1.28 ~mol P04/mg REL, RIF had 1.18 ~mol 
P04/mg RE~ and RIF H had a significant chang~ with a 
value of 1.56 ~mol P04/mg REL. PAOl REL was 12.8% 
P04 and 3.95% Pi. By comparison RIF G REL was 11.76% 
P04 and 3.66% Pi, and RIF H REL was 15.29% P04 and 
4.79% Pi. 
The REL fractions of susceptible and resistant cells 
were analyzed by thin layer chromatography (TLC) in a 
multisolvent system which separated the neutral lipids 
(nonpolar) and phospholipids (polar) (6). Analysis of· these 
chromatograms demonstrated significant qualitative (Figure 4) 
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TABLE I. 
COMPARISON 0~' REL AND P04 AND RIFAMYCIN 
ADAPTED STRAINS 
PAOl RIF G p RIF H 
%.REL 12.43(!1.67), 11.02(!0.57) (.025 11.69(!1.23) 
..,Ai~Ol P04/ 
19 REL 1.28(!0.18) 1.18(!0.28) ) .10 1.56(!0.27) 
%P04 12.80(!2.03) 11.76(!2.74) ).10 15.29(!2.63) 
%Pi 3.95(!0.54) 3.66(!0.83) ).10 4.79(!0.08) 
Values represent the aeans of seven to niney-two deterainations with standard 
deviations given in parentheses. 
Values detertined by perforaing the Student t test on the teans, etploying the 
two-tailed t table. P values of 0.05 and lower were considered statistically 











PE .. ~ ... PG • • 
A. " 
Figure 4. Relative Concentration of Major Phospholipids 
in REL in PAOl and Rifamycin Adapted Strains. 
FFA = Free Fatty Acids, DPG = DiphospPatidyl 
glycerol, PE = Phosphatidyl ethanolamine, 
PG = Phosphatidyl gycerol, S = Phospholipid 
Standards, PAOl = wild type Pseudomonas 
aeruginosa, RIF G, RIF H = Rifamycin 
Adapted Strains. 
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and quantitative changes (TABLE II). These changes occurred 
as a function of adapted rifamycin resistance. The lipid 
profile of RIF G and RIF H were significantly different in 
diphosphatidylglycerol (DPG) relative to the susceptible 
parent strain PAOl. Phosphatidylethanolamine (PE), 
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phosphatidylglycerol (PG) and free fatty acids (FFA) in the 
three strains, however, were unchanged. Comparitive analysis 
of percent REL phospholipids indicated that the percent FFA 
of PAOl, RIF G, and RIF H were 4.89%, 3.60% and 3.79% 
respectively. PAOl REL percent DPG was 5.90%, .RIF G was 
7.91% and RIF H was 9.61%. Both RIF G and RIF H percent DPG 
were considered significantly different. PAOl REL percent PE 
was 65.58% , RIF G was 66.82% and RIF H was 68.28%. The 
results for REL percent PG for PAOl, RIF G and RIFH was 
23.62%, 21.67%, 18.84% respectively. There were no 
significant changes in either PE or PG for RIF G and RIF H. 
Fatty Acid Composition 
The fatty acid composition of the REL fraction from PAOl 
and rifamycin adapted strains were analyzed by gas liquid 
chromatography (GLC) (37). Lipid analysis demonstrated 
significant qualitative and quantitative changes occurring in 
rifamycin adapted cells (TABLE III). The fatty acid profile 
of RIF G and RIF H were almost identical. In both RIF G and 
RIF H there occurred an almost two-fold increase in C14 
and a three-fold increase in C1s. A two-fold decrease 
in C1s:1 and C1s:1 was observed in both strains. A 
TABLE II 
COMPARISON OF MAJOR PHOSPHOLIPIDS iN REL IN PAOl AND 
RIFAMYCIN ADAPTED STRAINS 
% PA01 RIF G .p RIF H 
FFA 4.89(±2.30) 3. 60 ( ± 1. 29) ) .05 3.79(±1.03) 
DPG 5. 90( ± 1.26) 7.91!±2.70) ( .03 '!.61(±2.:35) 
PE 65.58(±7.06) 66. 82(±6. 06) >.OS 68.28(!4.68) 
PG 23.62(±7.39) 21.67(±6.27) ) . 40 1:3.:34(±4.00) 
Values represent the means of fifteen to eighteen determinations with standard 
deviations given in parentheses. 
Values determined by performing the Student t test on the means, employing 
the two-tailed t table. P values of 0.05 and lower were considered 
statistically significant. Comparison is with the PAOl strain. 
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FATTY ACID COMPOSITION OF REL FRACTION FROM PAOl AND 
RIFAMYCIN ADAPTED STRAINS 
Methyl Esters Area % for strain/rifamycin (6000 U/ml) in growth medium 
of Fatty Acids 
PA01/0 RIF G/6000 p RIF H/6000 p 
Saturated 
C14 0.48(±0.02) 0.74(±0.03) (.001 0.75(±0.07) (.025 
C16 37.12(±0.67) 47.381!2.93) ( .005 47.05(±2.10) (.001 
Cu 6.80(±0.28) 20.11 ( ± 1. 77) (.001 . 19. 82( ±0. 98) ( .001 
Unsaturated 
C16:! 1.88(±0.40) 0.44(±0.-37) (.005 0.85(±0.14). ( .005 
CiS:! 44.47(±1.91) 27. 36(t 1. 77) (.001 29.231!0.45) <.001 
Cyclopropane 
Ci7cy 2.23(±0.02) 0.65(±0.28) (.001 0.62(±0.12) (.001 
Cucr 5.02(±0.35) 0.66(±0.10) (.001 0.84(t0.39) (.001 
Cyclopropane/ 
Unsaturated 0.17 0.05 0.05 
Values represent the 1eans of three to seven determinations with standard 
deviations given in parentheses. 
Values deterained by performing the Student t test on the aeans, eaploying 
the ho-tailed t table. P values of 0.05 and lower were considered statistically 
significant. Coaparison is with the PA01 strain. 
Values approxiaate 100%due to rounding and ignoring of unidentified peaks. 
29 
four-fold decrease was found in cyclopropyl C17 and 
cyclopropyl C19 for both strains. PAOl REL was 0.48% 
C14, as compared to RIF G, 0.74% and RIF H, 0.75%. For 
C1a, PAOl REL was 6.80%, RIF G was 20.11% and RIF H was 
19.82%. For C1s, PAOl REL was 37.12%, RIF G was 47.38% 
and RIF H was 47.15%. All the saturated straight chain 
values were significant. PAOl REL was 44.47% C1a, while 
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RIF G was 27.86% and RIF H was 29.23%. PAOl REL was 1.88% 
C1s, RIF G was 0.44% and RIF H was 0.85%. All the 
differences between the parent strain and the adapted strains 
for the unsaturated fatty acids were statistically 
significant. The same was true for the cyclopropyl fatty 
acids. PAOl REL was 2.23% cyclopropyl C17, RIF G was 
0.65% and RIF H was 0.62%. PAOl REL was 5.02% cyclopropyl 
C19, RIF G was 0.66% and RIF H was 0.84%. The ratio for 
cyclopropyl fatty acids to unsaturated fatty acids were 0.17% 
for PAOl, 0.05% for RIF G and 0.05% for RIF H. 
LPS 
The LPS from PAOl and polymyxin adapted and reverted 
strains were isolated by the Darveau and Hancock method which 
isolated both smooth and rough forms of LPS (7). The percent 
LPS was determined gravimetrically (TABLE IV). PAOl percent 
LPS was 9.15%, IA was 10.79% and IAR was 10.29%. The 
resistant and reverted strains both had significant changes 
in the percent LPS. The percent phosphate was determined and 
both strains showed significant changes. PAOl LPS was 12.53% 
TABLE IV 
COMPARISON OF LPS AND P04 AND POLY B ADAPTED STRAINS 
PA01 IA p IAR p 
% LPS 9.15(±0.75) 10./9(±1.39) ( .025 10.29(±1.6'1) }.10 
umol P04/ 
mg LPS 1.29(±0.06) 1.57(±0.13) \.001 1. 05 ( ± 0. 09) (. 001 
u%P04 12.53(±0.57) 15. 31(! 1.17) ( .001 10.09 (!O. 9'i! ( .001 
%Pi . 4.04(±0.29) 4.88(±0.34) ( .001 3.20(±0.29) (.001 
Values represent the means of seven to twenty-one determinations with standard 
deviations given in parentheses. 
Values determined by performing the Student t test on the means, employing 
the two-tailed t table. P values of 0.05 and lower were considered statistically 
significant. Comparison is with the PAOI strain. 
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P04, IA was 15.31% and IAR was 10.09%. 
The carbohydrates in LPS in PAOl and polymyxin adapted 
strains were determined quantitatively. Both the IA and IAR 
percent hexose were significantly changed as compared to 
PAOl, with IAR approximating those of PAOl (TABLE V). PAOl 
LPS was 3.60% hexose, IA was 1.94% hexose and IAR was 2.42% 
hexose. IAR showed significant decrease in the percent KDO 
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present while IA did not change. PAOl LPS was 4.04% KDO, 
IAR was 4.17% and IAR was 3.64%. The percent heptose of IA 
was significantly higher than the PAOl wild type. The 
percent heptose of IAR was unchanged from that of PAOl. PAOl 
LPS was 8.94% heptose, IA was 9.44% and IAR was 9.02%. Both 
revertant and resistant strains demonstrated a significant 
change in the total carbohydrates. IA was significantly 
lower and IAR was significantly higher than the PAOl wild 
type strain. PAOl LPS was 10.15% total carbohydrates, IA was 
7.18% and IAR was 11.83%. 
The OM LPS of PAOl and polymyxin resistant and revertant 
strains along with the PAOl whole cell lipids were extracted 
by th~ saponification and esterfication method in Supelco 
bulletin #767A. The fatty acids esterfied to PAOl LPS are 
quite different from PAOl whole cell fatty acids (TABLE VI). 
PAOl LPS had a significantly greater percentage of 
3-hydroxydecanoate (3-0H C1o), 2- and 
3-hydroxydodecanoate (2- and 3-0H C12), dodecanoate 
(C12) and hexadecanoate (C1s). IA and IAR 
approximated the fatty acid content of wild type PAOl in 
TABLE v 
COMPARISON OF CARBOHYDRATES IN LPS IN PAOl AND POLY B 
ADAPTED STRAINS 
PA01 IA p IAR p 
Hexose 3.60(±0.26) 1.94(±0.13) {:001 2.42(±0.20) <.001 
KDO 4.04(!0.21) 4.17(±0.32) } .20 3.64(±0.32) (.005 
Heptose 8.94(±0.20) 9.44(±0.27) ( .001 9.02(±0.27) >.40 
Total 
Carbohydrate 10.15(±0:79) •7 .18(±0."89) <.001 11. 83( ± 1.50) < .005 
Values represent the 1eans of eight to twelve deter1inations with standard 
deviations given in parentheses. 
Values deterained by performing the Student t test on the 1eans, employing 
the two-tailed t table. P values of 0.05 and lower were considered statistically 
sigQificant. Co1parison is with the PA01 strain. 
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TABLE VI 
FATTY ACID COMPOSITION OF LPS FRACTION FROM PAOl AND 
POLY B ADAPTED STRAINS 
Hethyl Esters 
of Fatty Acids 
Area 1 for strain/poly B (6000 u/ai) in growth medium 
Hydroxy PA01 (WC)•/0 PA01/0 P IA/6000 P IAR/0 P 
3-0H Cto 4.6S 9.37 (.001 11.57 (.02S 13.95 (.001 
(±0.77) (±O.SO) (±1.52) (±2.01) 
2-0H Ctz 0.00 0.53 (.005 0.86 (.001 0.13 (.001 
(±0.00) (±0.27) (±0.26) (±0.02) 














































(.001 3.40 >.OS 0.13 (.001 
(!1.83) (!0.02) 
(.OS 0.00 (.001 0.66 ( .001 
(!0.00) (!0.11) 
<.001 19.89 >.OS 36.40 ( .001 
(!2.36) (±4.35) 
}.05 2.64 }.OS 2.49 } .05 
(±0.60) (±0.48) 
(.001 6.60 }.05 5.90 ( .001 
(±0.70) (±0.37) 
(.OOS 28.18 }.05 30.19 } .05 
(±2.76) (!1.09) 
(.001 2.49 (.001 1.65 (.01 
(±1.13) (±1.92) 
(.001 3.69 (.001 4.64 (.005 
(±0.44) (±1.98) 
Values represent the 1eans of three to nine deter1inations with standard deviations 
given in parentheses. 
Values deter1ined by perfor1ing the Student t test on the 1eans, e1ploying the 
two-tailed t table. P values of O.OS and lower were considered statistically 
significant. Co1parison is with the PAOl strain. 
*WC = Whole Cells 
Values approxi1ate 100% due to rounding and ignoring of unidentified peaks. 
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C1a:1 and C1a. PAOl fatty acids derived from whole 
cells had no measurable 2- or 3-0H C12, but had a 
significantly reduced 3-0H C1o in comparison with IA and 
IAR. IA LPS had no C12 and IAR had a significant 
decrease in C12. IA LPS and IAR LPS had little 
cyclopropyl fatty acids. 
In TABLE VII, IA LPS and IAR LPS are compared to 
PAOl LPS. The fatty acid compositions are significantly 
altered in the following fatty acids: 3-0H C1o, 3-0H C12, 
C12, C14, C1s, C1a, C1s: 1. IA had significant increases 
in the percentage of 3-0H C1o, 3-0H C12, C1s:1 and C1a:1. 
IAR LPS was significantly increased in the percentage of 
3-0H C1o, C1s:1, C1s and C1a. Both strains were reduced 
significantly in C12 and C14. The four most prominant fatty 
acid in IA were 3-0H C1o (11.57%), 3-0H C12 (12.54%), C1s 
(19.98%) and C1a:1 (28.18%). The four most prominant fatty 
acids in IAR were 3-0H C1o (13.95%), C1s:1 (5.80%), C1s 
(36.40%), and C1a:1 (30.19%). These were compared to the 
PAOl LPS which was 9.57% 3-0H C1o, 6.04% 3-0H C12, 4.18% 
C1s: 1, 25.92% C1s, and 23.55% C1a:1. 
Percent REL of RIF G was decreased significantly as 
compared to PAOl. The percent P04 of RIF G REL 
remained unaltered while RIF H REL percent P04 was 
significantly increased. REL percent DPG was significantly 
increased for both RIF G and RIF H, as were all the fatty 
acids in the REL. The percent LPS in the polymyxin strains 
were all significantly increased. The IA LPS percent 
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TABLE VII 
FATTY ACID COMPOSITION OF LPS FRACTION FROM PAOl 
AND POLY B ADAPTBD STRAINS 
Hethyl Esters 
of Fatty Acids 


































































Values represent the 1eans of three to nine deter1inations with standard 
deviations given in parentheses. 
Values deter1ined by perfor1ing the Student t test on the 1eans, 
eiPloying the two-tailed t table. P values of 0.05 and lower were 
considered statistically significant. Co1parison is with the PA01 strain. 
Values approxi1ate 100% due to rounding and ignoring of unidentified peaks. 
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P04 was significantly increased while the IAR LPS was 
significantly decreased. The hydroxy fatty acids results of 
the poly B strains indicate that the hydroxy fatty acids 
increase in response to antibiotic resistance. 
CHAPTER IV 
DISCUSSION 
Pseudomonas aeruginosa is resistant to a 
wide variety of antibacterial agents. It has the intrinsic 
mechanism to adapt to 6000 U/ml polymyxin B (poly B) and 
6000 U/ml rifamycin and can revert back to its original 
wild type susceptibility. Therefore, the resistant strains 
used in this study are adapted to the antibiotic, and are 
not true genetic mutant strains. Pseudomonas 
resistance to antibiotics such as poly B is due to low 
permeability in the outer membrane (OM). The favored sites 
for resistance are the phospholipids and lipopolysaccharide 
(LPS) which compromise the outer layer of the OM structure. 
Since antibiotic resistance to poly B in the pseudomonads 
is due in part as a function of alterations in the readily 
extractable lipids (REL), we studied the more non-polar 
rifamycin antibiotic to determine what changes there are in 
rifamycin-resistant REL. LPS, has been identified as a 
binding site for poly B, and was therefore studied in order 
to determine what role it plays in the resistance 
mechanism. We determined the percentage of total 
carbohydrates, phosphate and fatty acids of the LPS in wild 
type (PAOl), poly B-resistant strain (IA), and the 
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revertant strain (IAR). 
The rifamycin resistant strains, RIF G and RIF H, 
differed biochemically from the poly B-resistant strain, 
IA, as shown in the REL alterations. The percent REL of 
both RIF H and RIF G decreased as compared to the wild type 
PAOl, whereas the change in the percent REL for IA resulted 
in a significant increase. RIF G had a significant 
decrease in REL, whereas RIF H was similar to that of PAOl. 
RIF H and IA both had significant changes in the percent 
phosphate (~moljmg of REL) with RIF H increasing its 
percent phosphate and IA decreasing its percent phosphate. 
The percent REL and percent phosphate changes clearly are 
not identical for IA, RIF H and RIF G strains. Since poly 
B and rifamycin compete for binding space with phosphate, 
magnesium ions and calcium ions, the increase in phosphate 
prevents rifamycin from finding an adequate number of 
compatable binding sites on the OM surface. 
Thin layer chromatography revealed no differences in 
phospholipid content of the REL of RIF H and RIF G. The 
only significant change in the major phospholipids in the 
REL of the rifamycin-resistant strains was diphosphatidyl 
glycerol (DPG), whereby both strains had significant 
increases. The poly B resistant strain (IA) has 
significantly decreased phosphatidyl ethanolamine (PE) and 
phosphatidyl glycerol (PG), and significantly increased in 
its DPG. In the rifamycin-resistant strains, no 
significant loss of receptor phospholipids was found as was 
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detected in the poly 8-resistant strain, (IA). In the poly 
8-resistant system, there was a decreased number of 
phospholipid receptor sites, indicating an exclusion 
mechanism at the OM. The rifamycin-resistant system 
prevents the rifamycin molecule from binding due to a 
competition mechanism, whereby the phosphate molecule 
competes for space with the rifamycin molecule. 
In poly 8-resistant cells, the loss of the negatively 
charged phospholipids PG and PE could reduce the ability 
somewhat of the OM to bind polymyxin. The decreased 
percent of phosphate and the loss of acidic phospholipids, 
would make the OM of resistant cells more resistant to poly 
8 binding and give resistance, especially to low 
concentration of antibiotic, to the cell. The 
phospholipids have mainly a structtiral function in the OM 
due to the phospholipid's unusual physiochemical 
properties. Yet, the rifamycin-resistant cells did not 
demonstrate a significant loss of PE or PG. The 
concentration of phosphate did significantly increase in 
RIF H, however. 
The fatty acid compositiop of the RIF G and RIF H were 
almost identical results. However, the fatty acid content 
of rifamycin-resistant strains were different from the poly 
8 resistant strain. The IA strain had decreased percent 
·saturated straight chain fatty acids in comparison to PAOl, 
while RIF H and RIF G had increased percent saturated 
straight chain. The results were also opposite for the 
unsaturated straight chain fatty acids. IA had a 
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significantly increased amount of unsaturated fatty acids 
and the rifamycin strains had a significantly decreased 
amount. These diverges in fatty acid content could be due 
to the fact that rifamycin is much more non-polar than poly 
B. Decreasing the amount of unsaturated straight chain 
fatty acids facilitates the cell to become less amenable to 
penetration by a hydrophobic molecule. Peptide 
antibiotics, such as poly 8, form complexes with metal ions 
and disrupts the control of ion permeablitiy in the OM. 
Rifamyin, being a polyene antibiotic, interferes with 
proton and ion transport (8). 
The ratio of cyclopropane to unsaturated fatty acids 
decreased in the rifamycin strains. This was identical to 
changes noted in IA as compared to the wild type strain. 
These alterations in unsaturated/cyclopropyl ratio might be 
necessary in IA to bring about the proper OM fluidity 
characteristics in the presence of decreased OM LPS and 
protein; however, this is not true for the rifamycin 
strains. The amount of unsaturated fatty acid in the 
rifamycin strains actually decreases overall. The ratio 
demonstrates that the cyclopropyl fatty acids decrease more 
dramatically than the unsaturated fatty acids. Lowering 
the cyclopropane fatty acid content results in a fatty acid 
composition similar to that of mammalian cell membranes, 
which are more resistant to polymyxin than are bacterial 
cell membranes. 
The REL, phosphate and fatty acid alterations in the 
poly 8-resistant strains strongly suggested the existence 
of an exclusion mechanism previously discussed. However, 
the REL, phosphate and fatty acid changes in the rifamycin 
strains are not as dramatic, suggesting a different 
mechanism of resistance. Perhaps the main thrust of the 
cell's resistance lies in the cytoplasm. In a resistant 
mutant the RNA polymerase beta subunit binding site has a 
decreased affinity for the antibiotic (8). Therefore a 
partial exclusion mechanism whereby the OM calcium and 
magnesium ions compete for binding sites with the 
antibiiotic on the OM surface and a decreased affinity of 
the binding site in the cytoplasm would both seem to 
operate in the resistance mechanism. 
These experiments does not allow us to conclusively 
determine the mechanisms of resistance in the rifamycin 
strains. The OM is a dynamic structure and a change in 
one of its chemical components may be the cell mechanism 
for compensating for a change in another chemical 
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component. For example, the decrease in percent REL may be 
compensated for by an increase in porin proteins which 
could act to exclude the non-polar antibiotic. The 
increase in saturated fatty acids could be a compensation 
for the decrease in unsaturated fatty acids. This decrease 
in unsaturated fatty acids could make the OM less fluid and 
thus less responsive to the rifamycin molecule. Therefore, 
unless all components are monitored simultaneously, 
interpretations will be difficult, especially in a system 
such as the development of antibiotic resistance. 
In the second part of this study the role of LPS in 
the polymyxin B strains and its possible contribution to 
the mechanism of resistance was investigated. LPS 
constitutes a major role of the OM in terms of a 
permeability barrier. The data indicated that LPS also 
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plays a major role in the mechanism of resistance to 
antibiotics. Kropinski and his colleagues found that the 
altered LPS of antibiotic-supersusceptible cells resulted 
in a higher OM permeability (30). Tsang and his colleagues 
examined electron micrographs and poly-acrylamide gel 
electrophoresis of poly B-resistant and susceptible cells 
of Serratia marcescens and reported the 
formation of complexes between poly B and LPS in the 
susceptible cells (46). 
The smooth LPS (minus the 0 antigen) in 
Pseudomonas aeruginosa varies from 0.2 to 13.7 
mol% of the total LPS (24). For this reason, in our study 
the LPS isolation precedure of Darveau and Hancock was used 
as it isolates both smooth and rough pseudomonal types (7). 
The resistant strain IA showed a slight significant 
increase in the percent LPS, while the percent LPS of IAR 
was similar to PAOl. The rich phosphate content is found 
within the inner region of the LPS core, mostly in the 
heptose residues. The percent phosphate in IA increased in 
proportion to the increase in percent LPS, as did the 
percent heptose. The changes in the level of heptose is 
known to reflect the compositional variation in LPS (9). 
Our resistant cells produced only slight changes in the 
percent LPS, even though LPS composition changes in 
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accordance with environmental factors and that the cells 
respond by an increase or a decrease in the amount of LPS. 
Therefore, it is likely that the changes in LPS due to 
antibiotic resistance is in the LPS composition and not in 
the level of LPS. The percent total carbohydrate 
significantly increased and at the same time the percent 
KDO decreased. This could be of a compensatory nature. 
The low recovery of LPS could be due to the presence 
of acid-labile or other unusual components (32), possibly 
as a result of a lack of chemical modification during 
treatment (30). These calculations do not take into 
consideration the probability of incomplete release during 
hydrolysis and destruction following release. 
LPS directly influences the number of functional open 
. 
porin protein pores. The porin protein F is usually 
associated with LPS. Removal of LPS from porin protein 
renders the protein inactive in black lipid bilayer studies 
(31). LPS may interact with porin protein through charged 
phosphate groups or via hydrophobic interactions with acyl 
chains on lipid residues, in such a way as to determine 
their orientation or surface exposure. Several OM porin 
proteins were significantly reduced in one study using a 
poly a-resistant mutant strain (15). In several other 
studies, pseudomonal strains adapted to poly B resistance 
showed no such significant reduction (7)._ 
The largest difference between PAOl LPS and IA LPS was 
the change in fatty acid content. In comparing a 
pseudomonad wild type and a supersusceptible mutant 
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Kropinski found no significant alterations in the overall 
fatty acid content (30). Their study found several 
differences in the fatty acids of resistant and susceptible 
strains. The poly B-resistant strain, IA, had the five 
fatty acids most commonly found in the LPS of pseudomonad 
strains to include: 3-hydroxy decanoate (3-0H C1o), 
dodecanoate (C12), 2- and 3-hydroxy dodecanoate (2-
and 3-0H C12), and hexadecanoate (C1s). All the 
hydroxy fatty acids significantly increased in the IA 
strain, while 2- and 3- OH fatty acids significantly 
decreased in the IAR strain. There was· a significant 
decrease in the saturated fatty acid of IA with a 
corresponding increase in the unsaturated fatty acids. The 
cyclopropyl fatty acids slightly increased in the IA 
strain. The low 3-0H C12 level was due in part to 
the fact that it is released only after acid hydrolysis. 
We elected not to perform acid hydrolysis on the LPS as 
this is a harsh procedure and is responsible for the loss 
of a large percentage of hydroxy fatty aids (22). 
The REL, phosphate and fatty acid alterations in the 
rifamycin-resistant strains were not as extensive as the 
alterations in the REL of poly B-resistant strain, IA. 
Therefore the exclusion mechanism on the OM may not be the 
primary mechanism of antibiotic resistance. The fatty acid 
alterations for LPS and REL were very similar. There was a 
greater percent decrease in the IA LPS saturated fatty 
acids and a greater percent increase in the unsaturated 
fatty acids. Both REL and LPS fatty acids undergo similar 
alterations in antibiotic-resistant strains. These 
findings stongly suggest that the fatty acids play a major 




SUMMARY AND CONCLUSIONS 
This study looked at Pseudomonas aeruginosa, a primary 
opportunistic pathogen which has an intrinsic ability to 
adapt to 6000 U/ml of polymyxin B and 6000 U/ml rifamycin. 
I examined the differences in the readily extractable 
lipids (REL) between the wild type (PAOl) strain and the 
rifamycin adapted (RIF G and RIF H) strains, and the 
differences in the lipopolysaccharide (LPS) between PAOl, 
the polymyxin adapted (IA) strain, and the polymyxin 
deadapted (IAR) strain. The REL of rifamycin resistant 
strains was compared to the REL of polymyxin resistant 
strain. 
This study indicated that the alterations in the REL, 
phosphate and fatty'acids of the rifamycin strains as 
compared to the wild type strain were less statistically 
significant than those of the polymyxin strain. The major 
change in the phospholipids in the REL of the rifamycin 
resistant strains was diphosphatidyl glycerol (DPG), 
whereby both strains had significant increases. Both 
rifamycin resistant strains had a significant increase in 
the saturated fatty acid chains and a significant decrease 
in the unsaturated chains. It would be of value to monitor 
both the outer membrane (OM) fatty acids and the target 
47 
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site in the cytoplasm, the RNA polymerase. 
The major alterations in the OM LPS of polymyxin 
resistant strain IA were in the fatty acid content. All 
the hydroxy fatty acids in the IA strain showed significant 
increases. There was a significant decrease in the 
saturated fatty acids in the IA strain with a corresponding 
increase in the unsaturated fatty acids. The cyclopropyl 
fatty acids significantly increased in the IA strains. 
These alterations were similar to those of the REL of 
polymyxin resistant strains. These findings suggest that 
the OM fatty acids share a major role in the exclusion 
mechanism of polymyxin resistance. 
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